For the first time, WHO’s treatment suggestions involve a clear suggestion for the use of prolonged-performing injectable cabotegravir and rilpivirine (Taxi/RPV) in its place switching option for antiretroviral therapy (ART) for adults and adolescents who've achieved comprehensive viral suppression on oral Artwork and do not need active hepatitis B infection. https://goo.gl/maps/UueY6cwcpDNXRohh7